detail-1-01

ADVANCING
FOR ONE

✓ Life Sciences
✓ Medical Devices and Med-tech

✓ Biotech, Pharma and Biopharmaceuticals
✓ Healthcare, Digital Health and Health-tech

The pandemic has brought into sharp focus the critical need for the industry, academia, governments, regulators, and other stakeholders in the ecosystem to intensify their collaboration for ensuring healthcare innovation at scale and delivery with equitable access. With this context, the 20th edition of Asia’s largest Life Sciences and Healthcare forum will feature prominent government dignitaries, industry leaders, researchers, entrepreneurs, and other delegates, and explore the theme of Advancing for ONE: Shaping the next generation of humanized healthcare.

Sessions

24th -26th FEB FEATURED
Healthcare
One health
Health-Tech
AMR
R&D
Supply Chain
Innovation
Med-Tech
H
e
a
l
t
h
c
a
r
e
f
o
r
A
l
l
Global best practices on use of technology, improving patient experience, innovative financing mechanisms, and achieving Universal Healthcare.
Operationalizing the "One Health" approach Importance of cross-sectoral collaboration and what policy enablement would encourage the 'One Health' approach Healthcare Reimagined: Telemedicine, Wearables
& METAVERSE
Changes in patient’s journey and healthcare experience due to digital technology, next generation remote healthcare models, Metaverse – new possibilities and realities
Economic and Public Implications of
AMR
Factors accelerating the emergence and spread of AMR and urgent priorities and need for collaborative action.
Redefining Drug
R&D
Innovation
Role of data analytics and technology across the R&D process, potential of new technology platforms, and global best practices in R&D to develop, manufacture and supply innovative medicines
Global
Supply Chain
transformation
Role of investments, technology, regulatory and government support and ESG/Sustainability enablement practices
VCs & PEs Driving Innovation and Enabling Equity Key motivators for investment in a company such as new areas that give a competitive advantage to the Indian pharma. Med-tech Penetration - The Way Ahead Digital therapeutics, complex and innovative medical devices and regulatory transformation requirements

Schedule

DAY 1

Friday
24 Feb 2023
time-shape-top
10:30-11:30 am
1-1-new-copy-1-1-1-1-2
Inauguration of the 20th BioAsia Convention

Inauguration of the 20th BioAsia Convention by:
Shri. KT Rama Rao, Hon’ble Minister for Industries & Commerce, Government of Telangana

Guests of Honour:
Dr. VK Paul, Hon'ble Member (Health), NITI Aayog
Dr. Vas Narasimhan, CEO, Novartis

Mr. Jayesh Ranjan IAS, Principal Secretary (I&C), Govt of Telangana

11:30-12:00 pm
Dr. Vas Narsimhan (CEO, Novartis)
Keynote Address: Dr. Vas Narasimhan, CEO, Novartis, Switzerland
12:00-1:30 pm
1-1-new-copy-1-1-1-1
Panel Discussion - Operationalizing the "One Health" approach: Nexus of science, indigenous knowledge, policy
  • Importance of cross-sectoral collaboration: what are the expectations from each part of the ecosystem (what role are they expected to play/what contribution can they make)?
  • What policy enablement would encourage 'One Health' approach?
  • How to operationalize the 'One Health' approach in India?
Plenary Talk: Dr. Richard Hatchett, CEO, CEPI, UK (10 mins)
Panelists:

Panelists:

Chair: Dr. VK Paul, Hon'ble Member (Health), NITI Aayog

  • Dr. Richard Hatchett, CEO, CEPI, UK
  • Dr. Samit Hirawat, Executive Vice President, Chief Medical Officer, Global Drug Development, Bristol Myers Squibb, USA
  • Ms. Cynthia McCaffrey, UNICEF Representative to India
  • Dr. Mahender Nayak, Head of Asia Pacific, Takeda Pharmaceuticals, Singapore
  • Dr. Sai D. Prasad, Executive Director, Bharat Biotech International Ltd.

Moderator: Dr. Gagandeep Kang, Virologist and Professor, Dept. of Gastrointestinal Sciences, CMC Vellore

1:30–2:30 pm
Networking Lunch & Visit to the Exhibition
2:30–3:45 pm
this-also-new-1-3-1-1-1-1-removebg-preview (1)
Panel Discussion - Healthcare for all: Successes, challenges, and what next?
  • Where are we on our journey of achieving Universal Healthcare (recognizing the success thus far, discussing future action plan)?
  • How can we strengthen the healthcare infrastructure/resources availability (personnel and physical)?
  • What role can digital/ technology and data (e.g. real world data) play in improving healthcare access and outcome?
  • How can we increase focus on preventive healthcare in India (insurance, awareness in masses, behavior/mindset of population and healthcare system, focus on nutrition for all)?
  • What new innovative and sustainable financing mechanisms can be explored?
  • Global best practices/case studies on use of digital, improving patient awareness/experience, innovative financing mechanisms, and achieving Universal Healthcare.
Panelists:
  • Dr. Basant Garg IAS, Additional CEO, National Health Authority (NHA)
  • Dr. Shyam Bishen, Head, Shaping the Future of Health and Healthcare, Member of Executive Committee, World Economic Forum
  • Prof. K. Srinath Reddy, Honorary Distinguished Professor and Goodwill Ambassador, Public Health Foundation of India
  • Mr. Annaswamy Vaidheesh, CEO, North star Asia LLP
  • Dr. Prem Pavoor, Senior Partner, Head of India & Healthcare Investments, Eight Roads Ventures
  • Mr. Uday Bose, Head of Human Pharma Global Go-To-Market and Business Steering, Boehringer Ingelheim, Germany
  • Mr. Simpson Emmanuel, CEO & Managing Director, Roche Pharma India

Moderator: Mr. Vikas Dandekar, Editor - Pharma and Life Sciences, ET Prime

3:50–4:45 pm
1-3-2-1-1
Panel Discussion - Healthcare reimagined: Telemedicine, wearables, and healthcare in the METAVERSE
  • Changes in patient’s journey/healthcare experience due to digital technology?
  • Next generation remote health care models: home healthcare, virtual clinics (healthcare anywhere, anytime)?
  • Metaverse – new possibilities and realities?
Panelists:
  • Mr. Agam Upadhyay, SVP, Chief Technology Officer, GSK, USA
  • Mr. Philippe Houben, Head of GTM and Digital transformation - IMETA, Boehringer Ingelheim, UAE

Moderator: Mr. Ram Deshpande, Partner, Digital Transformation, EY

4:45–5:45 pm
Networking Break & Visit to the Exhibition
Presentation of the Genome Valley Excellence Award 2023 followed by Keynote Address:
Prof. Robert S. Langer, David H. Koch Institute Professor, Massachusetts Institute of Technology, USA
6:10-7:30 pm
1-4-1-copy-1-1-copy-2-2-1-315x315-1-removebg-preview (1)
CEO Conclave Panel Discussion
Future growth driver: What's next for India?

India continues to strengthen its foothold in the pharmaceutical industry – country’s leadership in generics was established long back, and COVID vaccines demonstrate industry’s success in rapid innovation capabilities.

What could drive the future growth for Indian pharmaceutical industry?

  • China plus one opportunity
  • Overcoming the uncertainty of global markets
  • Encouraging policy for enabling innovation and self-sustenance in KSMs and API (e.g., research linked incentives/RLI)
  • Further strengthen presence in biosimilars market
  • Contextualizing new areas (e.g. mRNA technology, CAR-T) to India and emerging markets
Panelists:

Chair: Mr. KT Rama Rao, Hon. Minister of I&C, Government of Telangana

  • Mr. Satish Reddy, Chairman, Dr. Reddy’s Laboratories
  • Mr. Ajay Piramal, Chairman, Piramal Group
  • Ms. Mahima Datla, Managing Director, Biological E Ltd.
  • Mr. Glenn Saldanha, MD and CEO, Glenmark Pharmaceuticals
  • Mr. Hari S Bhartia, Founder and Co-Chairman, Jubilant Bhartia Group

Moderator: Ms. Shereen Bhan, Managing Editor, CNBC-TV18

CEO Conclave Sponsor

7:30 pm
Networking Reception (Only for Invitees)

Business cocktail parties are a great opportunity to break out of your shell.

time-shape-bottom

DAY 2

Saturday
25 Feb 2023
time-shape-top
10:30-11:15 am
2-1-copy-1-2
Fireside chat

Dr. Sumbul Desai, VP Health, Apple, USA

Dr. Sangita Reddy, Joint Managing Director of Apollo Hospitals, India

11:20-12:25 pm
2-2-new-1-copy-1-1-1-1-315x315 copy
Panel Discussion - Data, analytics and technology to transform drug R&D: Redefining innovation
  • Benefits of using data analytics and technology across the R&D process, i.e. drug discovery to clinical trials (improved productivity and efficiency)
  • Potential of new technology platforms, e.g. cell & gene therapy, stem cell therapy, CRISPR, oncolytic viruses, RNAi
  • Success stories and challenges from Indian industry
  • Global best practices in R&D to develop, manufacture and supply innovative medicines
  • Importance of partnerships and collaborations
  • Opportunities for India pharma industry (including small biotechs and CRO)
Panelists:
  • Dr. S. Chandrasekhar, Secretary to the Government of India, Department of Science & Technology
  • Mr. Sauri Gudlavalleti, COO, Sai Life Sciences
  • Dr. Christine Durinx, Managing Director, VIB, Belgium
  • Mr. Mahesh Bhalgat, COO, Syngene
  • Dr. Arun Anand, COO, Immuneel Therapeutics
  • Prof. Rahul Purwar, Associate Professor – IIT Bombay, CEO & Founder, ImmunoACT

Moderator: Dr. Narendra Chirmule, Founder-director, SymphonyTech Biologics

Co-moderator: Ms. Anju Ghangurde, Executive Editor, Scrip

Session Sponsor

12:30-1:30 pm
panalist
Panel Discussion - India for India and India for world: Where does quality stand?
  • What challenges we face today in India regarding drug and device quality/quality perception?
  • What have we done to increase focus on drug and devices quality and how successful have we been?
  • What more needs to be done?
  • What are the real issues and how can we address those (e.g., infrastructure and people/training/culture investments to establish right quality frameworks, and establish quality by design?)
  • Will digital transformation help?
  • What other urgent initiatives do we need to take?
Panelists:
  • Mr. Mark Abdoo, Associate Commissioner for Global Policy and Strategy, US FDA
  • Dr. Carmelo Rosa, Director, Division of Drug Quality, CDER, US FDA
  • Dr. Sarah McMullen, Country Director - India, FDA
  • Prof. Sarfaraz K. Niazi, Adj. Professor of Pharmaceutical Sciences, University of Illinois, Chicago, USA
  • Mr. Ian White, Executive Director, NSF Health Sciences and Former GMDP Inspector, MHRA UK
  • Mr. Pavan Kumar Mocherla, EVP & President Greater Asia, BD
  • Mr. Michael Cutter, Chief Quality Officer, Biocon Biologics Ltd.

Moderator: Ms. Ekta Batra, Anchor & Associate Editor Research, CNBC-TV18

2:30–3:30 pm
2-4-copy-1-1-1-1-removebg-preview (4)
Panel Discussion - Med-tech penetration: What is the way ahead?
  • India has been strong in frugal innovation as also evidenced by some innovative COVID diagnostics: how can India continue to build strength?
  • Digital therapeutics (e.g. sensor and AI-based diagnostics and treatment) – with the inherent IT strength, how can India make it big in this space?
  • When and how will India foray into complex and innovative medical devices?
  • What are the regulatory transformation requirements?
Panelists:
  • Mr. Michael Blackwell, Vice President & Managing Director – India, Medtronic
  • Mr. Bhargav Kotadia, MD, Sahajanand Medical Technologies Ltd.
  • Mr. Shishir Agarwal, Managing Director, Terumo India Pvt. Ltd.
  • Mr. Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AiMeD)
  • Mr. Nikhil Srivastava, Managing Director, PAG

Session Sponsor

3:35–4:35 pm
this-also-new-1-3-1-1-1-1-removebg-preview (1)
Panel Discussion - Integrated Healthcare: the future of care delivery model

Globally, all healthcare systems are moving towards Integrated healthcare to improve overall health outcomes for patient and reduce healthcare costs.

  • Tech industry will contribute to next-generation health and the new interplay of strategic partnerships, advanced technologies, and data strategies in health care.
  • Interoperability is a very important requirement for integrated healthcare systems – what is the plan to ensure this?
  • What regulatory and policy interventions will be required for the entire ecosystem to work collaboratively, while keeping patients at the center?
  • How can technology enable providing healthcare in the hinterland? Is it easier to start integrated healthcare in the hinterland?
  • How will technology enable in drug registry and create measures to tackle counterfeit drugs?
Panelists:
  • Mr. Jayesh Ranjan IAS, Principal Secretary, Dept. of Industries & Commerce, Government of Telangana
  • Dr. Ramesh Byrapaneni, Managing Director, Endiya Partners
  • Mr. Jason Mitakidis, Founder, Cyclica and HealthWorks, Canada
  • Mr. Max Narr, CEO, Endosane Pharmaceuticals GmbH and Chief Investment Officer, Sanity Group, Germany
  • Mr. Alok Joshi, CEO, ABCD Technologies
  • Mr. Sanjeev Malhotra, CEO, Centre of Excellence for IOT & AI, NASSCOM

Moderator: Mr. Suresh Subramanian, Partner and National Life Sciences Leader, EY

4:40-5:40 pm
image-removebg-preview-4-Recovered__1_-removebg-preview
Panel Discussion - Global Supply chain transformation
  • Where are we two years post COVID? How much did India actually benefit from China Plus One strategy?
  • What further investments are required?
  • What regulatory and government support is needed?
  • What role can technology play?
  • ESG/Sustainability enablement practices in relation to manufacturing/supply chain? Adopting ESG as a culture
Panelists:
  • Ms. S Aparna IAS, Secretary to the Government of India, Department of Pharmaceuticals
  • Mr. Manni Kantipudi,CEO,Aragen Life sciences
  • Mr. Sanjiv Navangul, MD & CEO, Bharat Serums and Vaccines Ltd.
  • Mr. Suresh Pattathil, President OPPI and MD Abbvie, India
  • Mr. Narendra Otsawal, MD, Warburg Pincus

Moderator: Mr. Satish Reddy, Chairman, Dr. Reddy’s Laboratories

5:45-6:45 pm
ktr
Startup Showcase and Valedictory Ceremony

Chief Guest: Shri. KT Rama Rao, Hon’ble Minister for Industries & Commerce, Government of Telangana

7:00 pm
Gala Dinner (Only for Invitees)

time-shape-bottom

DAY 3

Sunday
26 Feb 2023
time-shape-top
10:30 am - 1:00 pm
Exhibition and Networking

Past Speakers

View all speakers
Mr. Bill
Gates
Bill Gates is a business magnate, investor, author, and philanthropist who  also co-founded Microsoft. Spoke at BioAsia 2022. Co-chair, Bill & Melinda Gates Foundation
Mr. Satya N
Nadella
Satya Naryana Nadella has also held leadership roles in both enterprise spanning a breadth of technologies and consumer businesses across the company.
Spoke at BioAsia 2021.
CEO, Microsoft
Mr. Alex Gorsky Alex Gorsky is also a member of the board of iconic global organizations including Apple and IBM.
Spoke at BioAsia 2022.
Executive Chairman, Johnson & Johnson
Mr. Geoff Martha Goeff Martha spearheads the world's leading medical technology company which offers solutions to treat a wide range of medical conditions. Spoke at BioAsia 2022. CEO & Chairman, Board of Directors, Medtronic Dr. Seth Berkley Dr Seth Berkley is also the founder, former president and CEO of the International AIDS Vaccine Initiative. Spoke at BioAsia 2012. CEO, GAVI Alliance

Speakers 2023

View all speakers
Dr. Vas Narasimhan Dr. Vas Narasimhan has done extensive work on a range of public health issues including development of over 20 novel medicines, advanced cell and gene therapies and vaccines. CEO, Novartis Prof. Robert Langer Prof. Robert Langer is a chemical engineer, scientist, entrepreneur, inventor and professor at MIT who has also co-founded Moderna Therapeutics. He has contributed extensively to the field of medicine and biotechnology. Professor at MIT and co-founder, Moderna Dr. Soumya Swaminathan Dr Soumya Swaminathan is an Indian paediatrician and clinical scientist known for her research on tuberculosis and HIV. Chief Scientist, WHO Dr. Rahul Singhvi Mr. Rahul Singhvi is the co-founder, director and CEO of National Resilience. He serves on the Executive Advisory Board of the LDI Health Economics at the University of Pennsylvania and on the Scientific Advisory Board of the anti-microbial resistance research group at the Singapore MIT Advance Research and Technology program. CEO, Resilience Dr. Richard Hatchett Dr. Richard Hatchett is an oncologist, epidemiologist and CEO of CEPI. For his distinguished service, he has been awarded the United States secretary of health and human services'. CEO, CEPI

Event Forecast

BioAsia 2023 will bring together the global industry leaders, researchers, policy makers, innovators, and investors together on one platform to intensify their collaboration for ensuring healthcare innovation at scale, and delivery with equitable access.
0+
Countries
0+
High Profile Speakers
0+
Corporates
0+
Partnering Meetings
0+
Participants

Gallery

ADVANCING FOR ONE Register Here